Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Barnabas Nyesiga"'
Autor:
Barnabas Nyesiga, Mattias Levin, Anna Säll, Anna Rosén, Kim Jansson, Sara Fritzell, Karin Hägerbrand, Dietmar Weilguny, Laura von Schantz
Publikováno v:
mAbs, Vol 16, Iss 1 (2024)
ABSTRACTDespite the large number of existing bispecific antibody (bsAb) formats, the generation of novel bsAbs is still associated with development and bioprocessing challenges. Here, we present RUBY, a novel bispecific antibody format that allows ra
Externí odkaz:
https://doaj.org/article/3554ed116f6c45079b118217d1d8fd6f
Autor:
Malin Lindstedt, Peter Ellmark, Lennart Greiff, Karin Hägerbrand, Laura von Schantz, Mia Thagesson, Doreen Werchau, Kristine Smedenfors, Anna Rosén, Anette Sundstedt, Adnan Deronic, Lill Ljung, Mattias Levin, Laura Varas, Anna Säll, Christina Sakellariou, Barnabas Nyesiga, David Gomez Jimenez, Mona Celander, Deniz Bölükbas, Fredrika Carlsson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Background Indications with poor T-cell infiltration or deficiencies in T-cell priming and associated unresponsiveness to established immunotherapies represent an unmet medical need in oncology. CD40-targeting therapies designed to enhance antigen pr
Externí odkaz:
https://doaj.org/article/3ded16f9cf504c5983b33e362b58d5fd
Autor:
Peter Ellmark, Karin Hägerbrand, Mia Thagesson, Doreen Werchau, Anna Rosén, Karin Barchan, Anette Sundstedt, Adnan Deronic, Lill Ljung, Mattias Levin, Laura Von Schantz, Laura Varas, Anna Säll, Barnabas Nyesiga, Eva Lindqvist
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/9e6a3658910c424b887736939f0b115c
Autor:
Lydia Nakiyingi, John Mark Bwanika, Bruce Kirenga, Damalie Nakanjako, Catherine Katabira, Gloria Lubega, Joseph Sempa, Barnabas Nyesiga, Heidi Albert, Yukari C Manabe
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e74023 (2013)
The existing diagnostic algorithms for sputum smear-negative tuberculosis (TB) are complicated, time-consuming, and often difficult to implement. The decision to initiate TB treatment in resource-limited countries is often largely based on clinical p
Externí odkaz:
https://doaj.org/article/4e4bce8593494278ac8133a4c59e2339
Autor:
Heidi Albert, Lydia Nakiyingi, Joseph Sempa, Olive Mbabazi, Sheena Mukkada, Barnabas Nyesiga, Mark D Perkins, Yukari C Manabe
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e72556 (2013)
BACKGROUND: Light emitting diode (LED) fluorescence microscopy (FM) is an affordable, technology targeted for use in resource-limited settings and recommended for widespread roll-out by the World Health Organization (WHO). We sought to compare the op
Externí odkaz:
https://doaj.org/article/55cda1d4b2534944a6a5dc09b60609c4
Autor:
Heidi Albert, Yukari Manabe, George Lukyamuzi, Patrick Ademun, Sheena Mukkada, Barnabas Nyesiga, Moses Joloba, C N Paramasivan, Mark D Perkins
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e15206 (2010)
BACKGROUND: Direct smear microscopy using Ziehl-Neelsen (ZN) staining is the mainstay of tuberculosis (TB) diagnosis in most high burden countries, but is limited by low sensitivity in routine practice, particularly in high human immunodeficiency vir
Externí odkaz:
https://doaj.org/article/6f29498525044b409098d430af29565b
Autor:
Barnabas Nyesiga, Mia Thagesson, Anna Rosén, Karin Hägerbrand, Mattias Levin, Karin Barchan, Laura Varas, Anette Sundstedt, Anna Säll, Doreen Werchau, Peter Ellmark, Lill Ljung, Laura Von Schantz, Eva Lindqvist, Adnan Deronic
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundAlligator's Neo-X-Prime platform aims to enable antigen presenting cells to efficiently enhance priming of tumor neoantigen-specific T cells with the goal of overcoming PD-1 resistance in certain tumor types. We hypothesize that binding of
Autor:
Karin Hägerbrand, Laura Varas, Adnan Deronic, Barnabas Nyesiga, Anette Sundstedt, Lill Ljung, Christina Sakellariou, Doreen Werchau, Mia Thagesson, David Gomez Jimenez, Lennart Greiff, Mona Celander, Kristine Smedenfors, Anna Rosén, Deniz Bölükbas, Fredrika Carlsson, Mattias Levin, Anna Säll, Laura von Schantz, Malin Lindstedt, Peter Ellmark
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e005018
BackgroundIndications with poor T-cell infiltration or deficiencies in T-cell priming and associated unresponsiveness to established immunotherapies represent an unmet medical need in oncology. CD40-targeting therapies designed to enhance antigen pre
Autor:
Barnabas Nyesiga, Zahra El-Schich
Publikováno v:
Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Publikováno v:
Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Cluster of differentiation (CD81) is a type of protein, which is encoded by CD81 gene. Beside that CD81 is also known under other names such as Target of the Antiproliferative Antibody 1 (TAPA-1) and Tetraspanin-28 (TSPAN28). Location of CD81 is know